However, until now, only one research from Wu focused on the close crosstalk between DAMPs and NETs in AP, revealing that HMGB1 could induce AP through activation of NETs and subsequent production of IL-1β, therefore a new therapeutic intervention could be attempted by targeting HMGB1 and NETs. The gene discussed is HMGB1; the disease is alkaline phosphatase measurement.